These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
216 related articles for article (PubMed ID: 18555938)
1. In vitro stability of two formulations of recombinant activated factor VIIa reconstituted in inappropriate solvents or at inappropriate volumes. Petersson B; Schönwandt AB; Thornstfeldt P; Nedergaard H; Jensen MB; Thornstergaard PB; Norsell T; Bjerre J Clin Ther; 2008 May; 30(5):917-23. PubMed ID: 18555938 [TBL] [Abstract][Full Text] [Related]
2. In vitro stability of lyophilized and reconstituted recombinant activated factor VII formulated for storage at room temperature. Nedergaard H; Vestergaard S; Jensen PT; Kristiansen MW; Jensen MB; Ostergaard PB; Norsell T; Bjerre J Clin Ther; 2008 Jul; 30(7):1309-15. PubMed ID: 18691990 [TBL] [Abstract][Full Text] [Related]
3. Feasibility of using recombinant factor VIIa in continuous infusion. Schulman S; Bech Jensen M; Varon D; Keller N; Gitel S; Horoszowski H; Heim M; Martinowitz U Thromb Haemost; 1996 Mar; 75(3):432-6. PubMed ID: 8701403 [TBL] [Abstract][Full Text] [Related]
4. Room-temperature-stable recombinant activated coagulation factor VII recombinant: chemical and microbiologic stability over 24 hours during continuous in vitro infusion. Christensen A; Jensen JT; Nøhr AM; Cooper DL Clin Ther; 2011 Dec; 33(12):1997-2001. PubMed ID: 22088413 [TBL] [Abstract][Full Text] [Related]
5. Stability of doripenem in vitro in representative infusion solutions and infusion bags. Psathas PA; Kuzmission A; Ikeda K; Yasuo S Clin Ther; 2008 Nov; 30(11):2075-87. PubMed ID: 19108795 [TBL] [Abstract][Full Text] [Related]
6. Chemical stability of two sterile, parenteral formulations of cyclophosphamide (Endoxan) after reconstitution and dilution in commonly used infusion fluids. Beijnen JH; van Gijn R; Challa EE; Kaijser GP; Underberg WJ J Parenter Sci Technol; 1992; 46(4):111-6. PubMed ID: 1453279 [TBL] [Abstract][Full Text] [Related]
7. Stabilization of a freeze-dried recombinant streptokinase formulation without serum albumin. López M; González LR; Reyes N; Sotolongo J; Pujol V J Clin Pharm Ther; 2004 Aug; 29(4):367-73. PubMed ID: 15271104 [TBL] [Abstract][Full Text] [Related]
9. A randomized, double-blind trial demonstrating bioequivalence of the current recombinant activated factor VII formulation and a new robust 25 degrees C stable formulation. Bysted BV; Scharling B; Møller T; Hansen BL Haemophilia; 2007 Sep; 13(5):527-32. PubMed ID: 17880439 [TBL] [Abstract][Full Text] [Related]
10. Enhancement of factor VIIa haemostatic efficacy by formulation with PEGylated liposomes. Yatuv R; Dayan I; Carmel-Goren L; Robinson M; Aviv I; Goldenberg-Furmanov M; Baru M Haemophilia; 2008 May; 14(3):476-83. PubMed ID: 18393980 [TBL] [Abstract][Full Text] [Related]
12. Stability of cefonicid sodium in infusion fluids. Wong WW; Maderich AB; Polli GP; Ravin LJ Am J Hosp Pharm; 1985 Sep; 42(9):1980-3. PubMed ID: 4050816 [TBL] [Abstract][Full Text] [Related]
13. Effect of X-ray radiation exposure on lyophilized recombinant activated factor VII (formulated for storage at room temperature). Vestergaard S; Nedergaard H; Jonasdottir O; Wagner Kristiansen M; Mette Nøhr A; Bjerre J Curr Med Res Opin; 2009 Nov; 25(11):2699-702. PubMed ID: 19775196 [TBL] [Abstract][Full Text] [Related]
14. Compounding of vitamin A, D3, E and K3 supplements for cystic fibrosis patients: formulation and stability study. Huyghebaert N; De Beer J; Vervaet C; Remon JP J Clin Pharm Ther; 2007 Oct; 32(5):489-96. PubMed ID: 17875116 [TBL] [Abstract][Full Text] [Related]
15. Antithrombin affects hemostatic response to recombinant activated factor VII in factor VIII deficient plasma. Szlam F; Taketomi T; Sheppard CA; Kempton CL; Levy JH; Tanaka KA Anesth Analg; 2008 Mar; 106(3):719-24, table of contents. PubMed ID: 18292408 [TBL] [Abstract][Full Text] [Related]
16. Effects of compounding and storage conditions on stability of pergolide mesylate. Davis JL; Kirk LM; Davidson GS; Papich MG J Am Vet Med Assoc; 2009 Feb; 234(3):385-9. PubMed ID: 19210262 [TBL] [Abstract][Full Text] [Related]
17. Pre-formulation and chemical stability studies of penethamate, a benzylpenicillin ester prodrug, in aqueous vehicles. Jain R; Wu Z; Bork O; Tucker IG Drug Dev Ind Pharm; 2012 Jan; 38(1):55-63. PubMed ID: 21696334 [TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetic properties of two different recombinant activated factor VII formulations. Morfini M; Jiménez-Yuste V; Eichler H; Fischer R; Kirchmaier CM; Scharling B; Bjerre J Haemophilia; 2012 May; 18(3):431-6. PubMed ID: 21999231 [TBL] [Abstract][Full Text] [Related]
19. Development of freeze-dried albumin-free formulation of recombinant factor VIII SQ. Osterberg T; Fatouros A; Mikaelsson M Pharm Res; 1997 Jul; 14(7):892-8. PubMed ID: 9244146 [TBL] [Abstract][Full Text] [Related]